ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

TVTX Travere Therapeutics Inc

6.30
-0.30 (-4.55%)
May 10 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Travere Therapeutics Inc TVTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.30 -4.55% 6.30 19:00:00
Open Price Low Price High Price Close Price Previous Close
6.66 6.26 6.88 6.30 6.60
more quote information »

Recent News

Date Time Source Heading
5/10/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/10/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:30GLOBETravere Therapeutics to Present at National Kidney..
5/08/202415:30GLOBETravere Therapeutics to Present at Upcoming Investor..
5/06/202415:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/06/202415:05EDGAR2Form 8-K - Current report
5/06/202415:01GLOBETravere Therapeutics Reports First Quarter 2024 Financial..
4/29/202415:30GLOBETravere Therapeutics to Report First Quarter 2024 Financial..
4/24/202406:05GLOBETravere Therapeutics and CSL Vifor Announce European..
4/24/202402:00PRNCACSL Vifor and Travere Therapeutics Announce European..
4/04/202415:30GLOBETravere Therapeutics to Present Abstracts at the Society for..
4/03/202415:30GLOBETravere Therapeutics to Present Abstracts on FILSPARI®..
3/13/202416:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
3/11/202406:05GLOBETravere Therapeutics Submits Supplemental New Drug..
2/26/202415:30GLOBETravere Therapeutics to Present at Upcoming Investor..
2/23/202415:05EDGAR2Form 8-K - Current report
2/23/202406:05GLOBETravere Therapeutics and CSL Vifor Announce Sparsentan..
2/23/202401:00PRNCACSL Vifor and Travere Therapeutics announce sparsentan..
2/20/202407:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/15/202415:05EDGAR2Form 8-K - Current report
2/15/202415:01GLOBETravere Therapeutics Reports Fourth Quarter and Full Year..
2/14/202413:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202415:30GLOBETravere Therapeutics to Report Fourth Quarter and Full Year..
2/02/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202420:58EDGAR2Form 144 - Report of proposed sale of securities
2/01/202420:58EDGAR2Form 144 - Report of proposed sale of securities
2/01/202420:57EDGAR2Form 144 - Report of proposed sale of securities
2/01/202415:30GLOBETravere Therapeutics to Present at the Guggenheim 6th Annual..
2/01/202411:44EDGAR2Form 144 - Report of proposed sale of securities
2/01/202408:52EDGAR2Form 144 - Report of proposed sale of securities
1/25/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202415:05GLOBETravere Therapeutics Announces Licensing Agreement with..
1/23/202412:17EDGAR2Form 144 - Report of proposed sale of securities
1/23/202409:51EDGAR2Form 144 - Report of proposed sale of securities
1/08/202406:07EDGAR2Form 8-K - Current report
1/08/202406:00GLOBETravere Therapeutics Provides Corporate Update and 2024..
1/05/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock